Seroepidemiological profile of pregnant women after inadvertent rubella vaccination in the state of Rio de Janeiro, Brazil, 2001-2002

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 19, Issue 6, 2006, Pages 371-378

  Da Silva E Sá, Gloria Regina ^a   Camacho, Luiz Antonio Bastos ^b   Siqueira, Marilda M ^b   Stavola, Mônica S ^a   Ferreira, Daise Almeida ^b  

^a Centro de Vigilância Epidemiológica   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Brazil; Epidemiological surveillance; Pregnancy; Rubella; Vaccination

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEASLES VACCINE; RUBELLA VACCINE;

EPIDEMIOLOGY; MATERNAL HEALTH; PREGNANCY; RUBELLA; VACCINATION;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CONGENITAL INFECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; MEASLES; PREGNANCY; RUBELLA; SEROEPIDEMIOLOGY; SEROLOGY; VACCINATION;

BRAZIL; RIO DE JANEIRO [BRAZIL]; SOUTH AMERICA;

RUBELLA;

EID: 33747420648     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/s1020-49892006000600002     Document Type: Article

References (28)

1. World Health Organization. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Geneva: WHO; 2000.
2. Plotkin SA. Rubella eradication. Vaccine. 2001;19:3311-9.
3. Brazil, Ministério da Saúde. Manual de vigilância epidemiológica das doenças exantemáticas - sarampo, rubéola e síndrome da rubéola congênita (SRC). 3a ed. Brasilia: Secretaria de Vigilância em Saúde; 2003.
4. Lanzieri TM, Segatto TC, Siqueira MM, Oliveira Santos EC, Jin L, Prevots R. The burden of congenital rubella syndrome after a community-wide rubella outbreak, Rio Branco, Acre, Brazil, 2000-2001. Ped Infect Dis J. 2003;22:323-9.
5. Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, Quadros CA. New horizons in the control of rubella in prevention of congenital rubella syndrome in the Americas. J Infect Dis. 2003; 187 (Suppl 1): S146-57.
6. Reef SE, Frey TK, Theall K, Abernathy E, Burnett CL, Icenogle J, et al. The changing epidemiology of rubella in the 1990s. On the verge of elimination and new challenges for control and prevention. JAMA. 2002;287(4):464-72.
7. Sam G. The epidemiology of rubella and congenital rubella in Australia. Meeting on preventing congenital rubella syndrome (CRS): immunization strategies, surveillance needs (working papers). Geneva: World Health Organization; 2000.
8. Brazil, Ministério da Saúde. Sistema Nacional de Agravos de Notificação (SINAN). 1998-2001. Brasilia: MS.
9. Brazil, SI-API-PNI / Assessoria de Doenças Imunopreveníveis / CVE / SES-RJ-DATASUS. Available from: www.datasus.gov.br. Accessed 15 April 2003.
10. Centers for Disease Control and Prevention. Notice to readers: revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR. 2001;50(49):1117-8.
11. Organização Mundial da Saúde. Estratégias e segurança da vacinação contra rubéola - informe final, Caracas: OMS; 2001.
12. Plotkin SA. Rubella vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: WB Saunders; 1999. Pp. 409-40.
13. Enders G. Rubella antibody titers in vaccinated and non-vaccinated women and results of vaccination during pregnancy. Rev Infect Dis. 1985; 7 (Suppl 1): S103-7.
14. Bar-Oz B, Levichek Z, Moretti ME, Mah C, Andreou S, Koren G. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am J Med Genet A. 2004;130(1):52-4.
15. Bart SW, Stetler HC, Preblud SR, Williams NM, Orenstein WA, Bart KJ, et al. Fetal risk associated with rubella vaccine: an update. Rev Infect Dis. 1985: 7(Suppl 1): S95-102.
16. Brazil, Ministério Da Saúde / Programa Nacional De Imunizações. Protocolo de atendimento e acompanhamento de recém-nascidos de mães vacinadas inadvertidamente contra rubéola. Brasília: MS; 2002.
17. Brazil, Secretaria de Estado de Saúde do Rio de Janeiro. Protocolo de atendimento e acompanhamento de recém-nascidos de mães vacinadas inadvertidamente contra rubéola. Rio de Janeiro; 2002.
18. Brasil, Ministério da Saúde. Secretaria de Vigilância em Saúde. Sistema de Informações de Nascidos Vivos. Available from: http://www.datasus.gov.br/catalogo/sinasc.htm. Accessed 2 September 2005.
19. Dean AG, Dean JA, Coulombier D, Burton AH, Brendel KA, Smith DC, et al. Epi Info, Version 6. Atlanta: Centers for Disease Control and Prevention; 1994.
20. Araujo JO, Maretti M. Repercussões da gravidez sobre o organismo. Anamnese e exame físico. In: Rezende J, ed. Obstetrícia. 7th ed. Rio de Janeiro: Guanabara Koogan; 1995. Pp. 170-82.
21. Chantler J, Wolinsky JS, Tingle A. Rubella virus. In: Knipe DM, Howley PM, eds. Fields virology, vol 1. Philadelphia: Lippincott, Williams & Wilkins; 2001. Pp. 963-90.
22. Best JM, O'Shea S, Tipples G, Davies N, Al-Khusaiby SM, Krause M. Interpretation of rubella serology in pregnancy - pitfalls and problems. BMJ. 2002; 325:147-8.
23. Hedman K, Rousseau A. Measurements of avidity of specific IgG for verification of recent primary rubella. J Med Virol. 1989;27:288-92.
24. Oliveira SA, Siqueira MM, Camacho LAB, Nogueira RM, Spinetti CCJ, Cubel Garcia, RCN, et al. The aetiology of maculopapular rash diseases in Niterói, State of Rio de Janeiro, Brazil: implications for measles surveillance. Epidemiol Infect. 2001;127:509-16.
25. Castro-Silva R, Siqueira MM, Oliveira SA, Amorim L, Ferreira DA, Cruz A, et al. Serological surveillance of rubella virus in Rio de Janeiro City. XI Meeting of Virology and III Mercosul Meeting of Virology, São Lourenço, 2000. Virus Rev Res. 2000;5:139.
26. Preblud SR, Stetler HC, Frank Jr JA, Greaves WL, Hinman AR, Herrmann KL. Fetal risk associated with rubella vaccine. JAMA. 1981;246(13):1413-7.
27. Ebbin AJ, Wilson MG, Chandor SB, Wehrle PF. Inadvertent rubella immunization in pregnancy. Am J Obstet Gynecol. 1973;117(4):505-12.
28. Modlin JF, Herrman K, Brandling-Bennett AD, Eddins DL, Hayden GF. Risk of congenital abnormality after inadvertent rubella vaccination of pregnant women. N Engl J Med. 1976; 294(18):972-4.